40 co op jobs found

As a leader in plasma collection, CSL Plasma is committed to excellence and innovation in everything we do. Our work helps to ensure that tens of thousands of people are able to live normal, healthy lives. We are committed to our work because lives depend on us. CSL Plasma operates one of the world’s largest and most sophisticated plasma collection networks, with more than 270 plasma collection centers in U.S., Europe and China and employs over 12,000 employees. CSL Plasma is vertically integrated, meaning plasma collected at CSL Plasma facilities is used by CSL Behring for the sole purpose of manufacturing and delivering its life-saving therapies to people in more than 70 countries. CSL Plasma is a subsidiary of CSL Behring, a global biotech leader and a member of the CSL Group of companies. The parent company, CSL Limited (ASX:CSL; USOTC:CSLLY), headquartered in Melbourne, Australia.

As a leader in plasma collection, CSL Plasma is committed to excellence and innovation in everything we do. Our work helps to ensure that tens of thousands of people are able to live normal, healthy lives. We are committed to our work because lives depend on us. CSL Plasma operates one of the world’s largest and most sophisticated plasma collection networks, with more than 270 plasma collection centers in U.S., Europe and China and employs over 12,000 employees. CSL Plasma is vertically integrated, meaning plasma collected at CSL Plasma facilities is used by CSL Behring for the sole purpose of manufacturing and delivering its life-saving therapies to people in more than 70 countries. CSL Plasma is a subsidiary of CSL Behring, a global biotech leader and a member of the CSL Group of companies. The parent company, CSL Limited (ASX:CSL; USOTC:CSLLY), headquartered in Melbourne, Australia.

For more than 125 years, Boehringer Ingelheim has been committed to the research and development of innovative medicines that help bring more health to patients and their families. As a privately-held, family-owned pharmaceutical company, Boehringer Ingelheim is able to take a long-term view and invest heavily in science.

For more than 125 years, Boehringer Ingelheim has been committed to the research and development of innovative medicines that help bring more health to patients and their families. As a privately-held, family-owned pharmaceutical company, Boehringer Ingelheim is able to take a long-term view and invest heavily in science.

For more than 125 years, Boehringer Ingelheim has been committed to the research and development of innovative medicines that help bring more health to patients and their families. As a privately-held, family-owned pharmaceutical company, Boehringer Ingelheim is able to take a long-term view and invest heavily in science.

For more than 125 years, Boehringer Ingelheim has been committed to the research and development of innovative medicines that help bring more health to patients and their families. As a privately-held, family-owned pharmaceutical company, Boehringer Ingelheim is able to take a long-term view and invest heavily in science.

For more than 125 years, Boehringer Ingelheim has been committed to the research and development of innovative medicines that help bring more health to patients and their families. As a privately-held, family-owned pharmaceutical company, Boehringer Ingelheim is able to take a long-term view and invest heavily in science.

For more than 125 years, Boehringer Ingelheim has been committed to the research and development of innovative medicines that help bring more health to patients and their families. As a privately-held, family-owned pharmaceutical company, Boehringer Ingelheim is able to take a long-term view and invest heavily in science.

For more than 125 years, Boehringer Ingelheim has been committed to the research and development of innovative medicines that help bring more health to patients and their families. As a privately-held, family-owned pharmaceutical company, Boehringer Ingelheim is able to take a long-term view and invest heavily in science.

For more than 125 years, Boehringer Ingelheim has been committed to the research and development of innovative medicines that help bring more health to patients and their families. As a privately-held, family-owned pharmaceutical company, Boehringer Ingelheim is able to take a long-term view and invest heavily in science.

We came to Biogen to make an impact, to transform rigorous science into first-in-class medicines. We stay to create new possibilities together. We strive for excellence and go beyond the expected because we care deeply about making a difference for the many people we serve.

We came to Biogen to make an impact, to transform rigorous science into first-in-class medicines. We stay to create new possibilities together. We strive for excellence and go beyond the expected because we care deeply about making a difference for the many people we serve.

We came to Biogen to make an impact, to transform rigorous science into first-in-class medicines. We stay to create new possibilities together. We strive for excellence and go beyond the expected because we care deeply about making a difference for the many people we serve.

We came to Biogen to make an impact, to transform rigorous science into first-in-class medicines. We stay to create new possibilities together. We strive for excellence and go beyond the expected because we care deeply about making a difference for the many people we serve.

We came to Biogen to make an impact, to transform rigorous science into first-in-class medicines. We stay to create new possibilities together. We strive for excellence and go beyond the expected because we care deeply about making a difference for the many people we serve.

We came to Biogen to make an impact, to transform rigorous science into first-in-class medicines. We stay to create new possibilities together. We strive for excellence and go beyond the expected because we care deeply about making a difference for the many people we serve.

We came to Biogen to make an impact, to transform rigorous science into first-in-class medicines. We stay to create new possibilities together. We strive for excellence and go beyond the expected because we care deeply about making a difference for the many people we serve.

We came to Biogen to make an impact, to transform rigorous science into first-in-class medicines. We stay to create new possibilities together. We strive for excellence and go beyond the expected because we care deeply about making a difference for the many people we serve.

You’ve worked hard to become the professional you are today and are now ready to take the next step in your career. How will you put your skills, experience and passion to work toward your goals? At Amgen, our shared mission—to serve patients—drives all that we do.

You’ve worked hard to become the professional you are today and are now ready to take the next step in your career. How will you put your skills, experience and passion to work toward your goals? At Amgen, our shared mission—to serve patients—drives all that we do.